E7 TCR T cell induction immunotherapy

E7 TCR T cell induction immunotherapy · National Cancer Institute (NCI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7 TCR T cell induction immunotherapy, covering 2021-12-08 to 2021-12-08. Get the full timeline:

Most recent: Clinical Trial Update: E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer [EARLY_Phase 1]